Humate-P Alternatives Compared
Humate-P | Desmopressin | DDAVP |
|
---|
Humate-P (antihemophilic factor/von willebrand factor) | Desmopressin | DDAVP (desmopressin) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for von Willebrand Disease, Hemophilia A. Humate-P may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Diabetes Insipidus, von Willebrand Disease, Primary Nocturnal Enuresis, Nocturia, Hemophilia A. desmopressin may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Diabetes Insipidus, von Willebrand Disease, Primary Nocturnal Enuresis, Hemophilia A. DDAVP may also be used for purposes not listed in this medication guide. |
Related suggestions von Willebrand Disease
Hemophilia A
|
|||||||||||||||||||||||
More about Humate-P (antihemophilic factor/von willebrand factor) | More about Desmopressin | More about DDAVP (desmopressin) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Humate-P has an average rating of 10.0 out of 10 from a total of 3 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Desmopressin has an average rating of 9.0 out of 10 from a total of 41 ratings on Drugs.com. 89% of reviewers reported a positive effect, while 3% reported a negative effect. |
DDAVP has an average rating of 9.6 out of 10 from a total of 9 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: Humate-P side effects in more detail. |
See also: desmopressin side effects in more detail. |
See also: DDAVP side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
N/A |
Lower cost generic |
|||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Humate-P prices |
View all desmopressin prices |
View all DDAVP prices |
||||||||||||||||||||||||
Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Other antihemophilic factor/von willebrand factor brands include: Alphanate, Dried Factor VIII Fraction Type 8Y, Wilate | DDAVP, DDAVP Nasal, DDAVP Rhinal Tube, Minirin, Nocdurna | Other desmopressin brands include: DDAVP Nasal, DDAVP Rhinal Tube, Minirin, Nocdurna | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
24 hours |
4 hours |
4 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 6 drugs are known to interact with Humate-P:
|
A total of 122 drugs are known to interact with desmopressin:
|
A total of 122 drugs are known to interact with DDAVP:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
N/A |
September 06, 1995 |
N/A |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
||||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.